Healthcare Litigation Pharmaceuticals 
IP Watchdog
AUGUST 7, 2022
recently in Novartis Pharmaceuticals Corp. Accord Healthcare Inc. But in Novartis Pharmaceuticals v. Accord Healthcare, neither of the panel members in the majority of the original opinion even agreed to rehear the case, let alone agreed to reverse their prior ruling. Talk about snatching victory from the jaws of defeat!
InHouseBlog
APRIL 8, 2022
VP, Litigation & Employment Law , www.princetonlegal.com (Princeton, NJ). Senior Director, Compliance Risk Navigation , Regeneron Pharmaceuticals (Tarrytown, NY). Regulatory Litigation Attorney , Southern California Edison (Hybrid Remote). Director, IP Litigation , Inscripta, Inc. Legal Counsel , TuneIn (Remote).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
IP Watchdog
AUGUST 12, 2024
Supreme Court’s reasoning in Helsinn Healthcare v. Teva Pharmaceuticals (2019), the Federal Circuit rejected Celanese’s contentions that statutory changes wrought by the America Invents Act (AIA) altered the on-sale bar such that sales of products manufactured by an undisclosed process would not invalidate patents claiming that process.
IP Watchdog
JUNE 21, 2022
Court of Appeals for the Federal Circuit issued a precedential decision in Novartis Pharmaceuticals Corp. Accord Healthcare, Inc. Earlier today, the U.S. granting a petition for rehearing from appellant HEC Pharm Co.,
Complex Discovery
MARCH 12, 2025
Healthcare and Pharma Consolidation: With regulatory shifts and technological advancements in biotech, pharmaceutical mergers are increasing, driven by both innovation and cost-saving incentives. Poor governance can also lead to litigation risks if sensitive data is mismanaged. The solution?
IP Watchdog
MAY 3, 2022
On April 29, the United States Court of Appeals for the Federal Circuit (CAFC) affirmed in part, reversed in part, vacated in part, and remanded a decision of the United States District Court for the Northern District of Illinois regarding alleged infringement by U.S. Venture Inc., Sunoco).
Complex Discovery
NOVEMBER 3, 2024
Such capabilities are essential for addressing the challenges of cross-border litigation and vast data volumes, ensuring higher efficiency and accuracy. UnitedLex appointed Renee Meisel as its new CEO, signaling a shift toward bolstered leadership aimed at driving innovation across its litigation and compliance offerings.
Expert insights. Personalized for you.
78 
Let's personalize your content